approval · primary record
APIXABAN
3 approval events · latest 2026-09-25
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-09-25 |
| Approval events | 3 |
| Brand | APIXABAN |
| Sponsor | LUPIN |
| Route | ORAL |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-09-25 | FDA | NDA | APIXABAN | LUPIN | ORAL |
| 2026-06-29 | FDA | NDA | ABANTA | AZURITY | ORAL |
| 2026-06-24 | FDA | NDA | ELIQUIS | BRISTOL | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:27:54.065Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:apixaban
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.